Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
19000 participants
OBSERVATIONAL
2025-12-01
2026-08-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dose Response Study of Aerobic Exercise in Older Adults
NCT01129115
Healthy Aging Through Optimized Exercise
NCT07093216
Effectiveness of a Physical Activity Intervention for Pre-frail Older Adults With Chronic Pain.
NCT04045535
An Investigation Into the Effects of Acute Exercise on Activities of Daily Living and Cognition in Older Adults
NCT06085235
Role of Aging and Individual Variation in Exercise Training Responsiveness
NCT06471569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1 - Control
0 or less than 1 day per week, with each session, on average \< 15 minutes.
Control
0 or less than 1 day per week, with each session, on average \< 15 minutes.
Arm 2 - Exercise
\>/= 2 days per week of moderate or vigorous intensity, with each session, on average, \>/=20 minutes in duration.
Exercise
\>/= 2 days per week of moderate or vigorous intensity, with each session, on average, \>/=20 minutes in duration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control
0 or less than 1 day per week, with each session, on average \< 15 minutes.
Exercise
\>/= 2 days per week of moderate or vigorous intensity, with each session, on average, \>/=20 minutes in duration.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Among participants reporting low exercise at Q0 (i.e., 0 or less than 1 day/week, with each session \<15 minutes in duration), completion of an exercise survey at Q1 as part of PLCO standard trial procedures no later than 5 years after reporting non-exercising status \[i.e., no exercise) at Q0.
* No evidence of any of the following absolute contraindications to exercise: uncontrolled hypertension, symptomatic valvular disease; hypertrophic cardiomyopathy; unstable angina pectoris; primary pulmonary hypertension; heart failure; severe arrhythmia; diagnosed dementia; any form of cancer other than non-melanoma, and severe infectious disease.
55 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
City of Hope Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City of Hope Medical Center
Duarte, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25603
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.